Advanced search
Publication Cover
Biotechnology & Biotechnological Equipment Volume 38, 2024 - Issue 1
Submit an article Journal homepage
360
Views
0
CrossRef citations to date
0
Altmetric
Research Article

A galantamine–curcumin hybrid lacks the depressant side effect of acetylcholinesterase inhibitors

Ivanka Kostadinovaa Department of Pharmacology, Pharmacotherapy and Toxicology, Faculty of Pharmacy, Medical University of Sofia, Sofia, BulgariaCorrespondence[email protected]
View further author information
,
Mariyana Atanasovab Department of Chemistry, Faculty of Pharmacy, Medical University of Sofia, Sofia, BulgariaView further author information
,
Georgi Stavrakovb Department of Chemistry, Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria;c Institute of Organic Chemistry with Centre of Phytochemistry, Bulgarian Academy of Sciences, Sofia, BulgariaView further author information
,
Irena Philipovac Institute of Organic Chemistry with Centre of Phytochemistry, Bulgarian Academy of Sciences, Sofia, BulgariaView further author information
&
Irini Doytchinovab Department of Chemistry, Faculty of Pharmacy, Medical University of Sofia, Sofia, BulgariaView further author information
Article: 2305903 | Received 30 Jun 2023, Accepted 10 Jan 2024, Published online: 29 Jan 2024

References

  • Birks J. Cholinesterase inhibitors for Alzheimer’s disease. Cochrane Database Syst Rev. 2006;2006(1):1. doi: 10.1002/14651858.CD005593.
  • Craig D, Birks J. Galantamine for vascular cognitive impairment. Cochrane Database Syst Rev. 2006;1(4):CD004746. doi: 10.1002/14651858.CD004746.pub2.
  • Katz NK, Barohn RJ. The history of acetylcholinesterase inhibitors in the treatment of myasthenia gravis. Neuropharmacology. 2021;182:108303. doi: 10.1016/j.neuropharm.2020.108303.
  • Sharma K. Cholinesterase inhibitors as Alzheimer’s therapeutics (review). Mol Med Rep. 2019;20(2):1479–6. doi: 10.3892/mmr.2019.10374.
  • World Health Organization. Depressive disorder (depression). [cited 2023 Jun]. Available from: https://www.who.int/en/news-room/fact-sheets/detail/depression
  • Mitić M, Lazarević-Pašti T. Does the application of acetylcholinesterase inhibitors in the treatment of Alzheimer’s disease lead to depression? Expert Opin Drug Metab Toxicol. 2021;17(7):841–856. doi: 10.1080/17425255.2021.1931681.
  • Stavrakov G, Philipova I, Lukarski A, et al. Galantamine–curcumin hybrids as dual-site binding acetylcholinesterase inhibitors. Molecules. 2020;25(15):3341. doi: 10.3390/molecules25153341.
  • Simeonova R, Zheleva D, Valkova I, et al. A novel galantamine–curcumin hybrid as a potential multi-target agent against neurodegenerative disorders. Molecules. 2021;26(7):1865. doi: 10.3390/molecules26071865.
  • Mladenova K, Stavrakov G, Philipova I, et al. A galantamine–curcumin hybrid decreases the cytotoxicity of amyloid-beta peptide on SH-SY5Y cells. Int J Mol Sci. 2021;22(14):7592. doi: 10.3390/ijms22147592.
  • Simeonova R, Atanasova M, Stavrakov G, et al. Ex vivo antioxidant and cholinesterase inhibiting effects of a novel galantamine–curcumin hybrid on scopolamine-induced neurotoxicity in mice. Int J Mol Sci. 2022;23(23):14843. doi: 10.3390/ijms232314843.
  • Fusar-Poli L, Vozza L, Gabbiadini A, et al. Curcumin for depression: a meta-analysis. Crit Rev Food Sci Nutr. 2020;60(15):2643–2653. doi: 10.1080/10408398.2019.1653260.
  • Castagné V, Moser P, Porsolt RD. Behavioral assessment of antidepressant activity in rodents. In: Buccafusco JJ, editor. Methods of behavior analysis in neuroscience. 2nd ed. Boca Raton (FL): CRC Press/Taylor & Francis; 2009.
  • Haam J, Yakel JL. Cholinergic modulation of the hippocampal region and memory function. J Neurochem. 2017;142(Suppl 2):111–121. doi: 10.1111/jnc.14052.
  • Cryan JF, Mombereau C, Vassout A. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev. 2005;29(4–5):571–625. doi: 10.1016/j.neubiorev.2005.03.009.
  • Tecott LH, Wehner JM. Mouse molecular genetic technologies: promise for psychiatric research. Arch Gen Psychiatry. 2001;58(11):995–1004. doi: 10.1001/archpsyc.58.11.995.
  • Bućan M, Abel T. The mouse: genetics meets behaviour. Nat Rev Genet. 2002;3(2):114–123. doi: 10.1038/nrg728.
  • Tecott LH. The genes and brains of mice and men. Am J Psychiatry. 2003;160(4):646–656. doi: 10.1176/appi.ajp.160.4.646.
  • Cryan JF, Markou A, Lucki I. Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci. 2002;23(5):238–245. doi: 10.1016/s0165-6147(02)02017-5.
  • Rupniak NM. Animal models of depression: challenges from a drug development perspective. Behav Pharmacol. 2003;14(5–6):385–390. doi: 10.1097/01.fbp.0000087738.21047.91.
  • Chatterjee M, Jaiswal M, Palit G. Comparative evaluation of forced swim test and tail suspension test as models of negative symptom of schizophrenia in rodents. ISRN Psychiatry. 2012;2012:595141–595145. doi: 10.5402/2012/595141.
  • Arndt DL, Peterson CJ, Cain ME. Differential rearing alters forced swim test behavior, fluoxetine efficacy, and post-test weight gain in male rats. PLoS One. 2015;10(7):e0131709. doi: 10.1371/journal.pone.0131709.
  • Castañé A, Kargieman L, Celada P, et al. 5-HT2A receptors are involved in cognitive but not antidepressant effects of fluoxetine. Eur Neuropsychopharmacol. 2015;25(8):1353–1361. doi: 10.1016/j.euroneuro.2015.04.006.
  • Zhang Y, Li L, Zhang J. Curcumin in antidepressant treatments: an overview of potential mechanisms, pre-clinical/clinical trials and ongoing challenges. Basic Clin Pharmacol Toxicol. 2020;127(4):243–253. doi: 10.1111/bcpt.13455.
  • Lopresti AL. Potential role of curcumin for the treatment of major depressive disorder. CNS Drugs. 2022;36(2):123–141. doi: 10.1007/s40263-022-00901-9.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.